Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Preventing Community-Acquired Pneumonia in Adults: A Population-Based Cohort Study
PPV23 showed no effect in preventing CAP in adults aged ≥18 years or in the subgroup aged ≥65 years, even if vaccinated <2 years previously.
Authors
- Jordi Almirall (ORCID: https://orcid.org/0000-0002-3821-4341)
- Àngel Lavado (ORCID: https://orcid.org/0000-0003-4370-9864)
- Mateu Serra‐Prat (ORCID: https://orcid.org/0000-0002-6554-9913)
- Ignasi Bolibar Ribas (ORCID: https://orcid.org/0000-0002-4529-1935)
- Elísabet Palomera (ORCID: https://orcid.org/0000-0002-4384-5746)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Maresme Health Consortium (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
Publication Details
- Journal
- Vaccines
- Published
- 2024-09-06
- DOI
- https://doi.org/10.3390/vaccines12091023
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.39